Login / Signup

Prevalence, treatment status, and predictors of anemia and erythropoietin hyporesponsiveness in Japanese patients with non-dialysis-dependent chronic kidney disease: a cross-sectional study.

Shigeru TanakaHiromasa KitamuraKazuhiko TsuruyaTakanari KitazonoToshiaki Nakanonull null
Published in: Clinical and experimental nephrology (2022)
Our findings demonstrate that many Japanese patients with non-dialysis-dependent CKD receiving ESAs fail to maintain adequate hemoglobin levels. These results suggest the need for interventions for ESA hyporesponsiveness factors in addition to iron supplementation.
Keyphrases
  • chronic kidney disease
  • end stage renal disease
  • physical activity
  • risk factors
  • iron deficiency
  • recombinant human
  • red blood cell
  • replacement therapy